Cytochrome P450 2A6 Inhibitors [MoA] - N0000193937
Pharmacologic Class Information
| Pharmacologic Code | N0000193937 |
| Pharmacologic Name | Cytochrome P450 2A6 Inhibitors |
| Pharmacologic Uses |
|
| Pharmacologic Concept | Mechanisms of Action - [MoA] |
| Pharmacologic Concept Description | This concept refers to the mechanism of action pharmacologic action at the receptor, membrane, or tissue level. In MED-RT, molecular, subcellular, or cellular effects of drug generic ingredients, organized into a chemical function classification hierarchy, beneath the "Cellular or Molecular Interactions" concept. |
NDC Products with Cytochrome P450 2A6 Inhibitors
The table contains 1 products whose active ingredient are classified under the same pharmacologic class Cytochrome P450 2A6 Inhibitors [MoA].
| NDC | Proprietary Name | Non-Proprietary Name | Dosage Form | Route Name | Company Name | Status | |
|---|---|---|---|---|---|---|---|
| 0078-0937 | Egaten | Non-Proprietary Name: Triclabendazole | Tablet | Oral | Novartis Pharmaceuticals Corporation | ACTIVE |